| WHO - Prequalification of Medical Products (IVDs, Medicines, Vaccines and Immunization Devices, Vector Control)

11th Invitation for Expression of Interest (EOI) for Active Pharmaceutical Ingredients (APIs)

Medicine Update

7 October, 2016 - 02:00 (CEST)

The 11th invitation to manufacturers of active pharmaceutical ingredients (APIs) to submit an expression of interest (EOI) for API prequalification to the WHO Prequalification Team: medicines (PQTm

WHO Public Assessment Reports (WHOPARs) published

Announcement

14 October, 2025 - 07:30 (CEST)

WHO Public Assessment Reports (WHOPARs) published

Announcement

9 October, 2025 - 15:14 (CEST)

Training for IVDs assessors for WHO Prequalification WHO Academy Lyon, 7-9 October 2025

IVD

Information note

9 October, 2025 - 15:09 (CEST)

A core component of the Prequalification assessment process relates to technical review of the product dossier and change requests.

WHO Public Assessment Reports (WHOPARs) published

Announcement

9 October, 2025 - 09:37 (CEST)

First lenacapavirs prequalified

6 October, 2025 - 00:12 (CEST)

Gilead’s Lenacapavir Tablet and Injection Products Prequalified by WHO

Incepta’s medroxyprogesterone susp for injection prequalified

1 October, 2025 - 00:12 (CEST)

WHO Prequalification Unit (PQT) added the below new product to its prequalified list:

Annual UN meeting with manufacturer and suppliers: Updates on IVDs

IVD

Alerts

30 September, 2025 - 15:25 (CEST)

The 2025 UNFPA-UNICEF-WHO Annual Meeting is taking place online from 29 September to 3 October 2025. The theme of the 2025 Joint Meeting was “Delivering in times of D

WHO Public Assessment Reports (WHOPARs) published

Announcement

30 September, 2025 - 14:15 (CEST)

WHO Public Assessment Reports (WHOPARs) published

Announcement

19 September, 2025 - 13:15 (CEST)

Subscribe to